ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugMoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics AG Logo
Verified· 3 sources

MoonLake Immunotherapeutics AG

Summary

About the company

The core activity of MoonLake Immunotherapeutics AG is the development of innovative therapies for inflammatory diseases, particularly with the goal of improving the treatment of diseases such as psoriasis and hidradenitis suppurativa. The company focuses on the development of Sonelokimab, a Nanobody that specifically inhibits interleukins to reduce inflammation. The core activities include conducting clinical trials, developing new therapies, and licensing medications.

AI-generated
Press

Media

July 17, 2026Media
Moonlake Therapeutics raises USD 230 million in public offering
startupticker.ch
April 3, 2025Media
MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing
startupticker.ch
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Knowledge

No knowledge articles yet

Once MoonLake Immunotherapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

MoonLake Immunotherapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MoonLake Immunotherapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MoonLake Immunotherapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Dorfstrasse 29
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-433.093.536
Founded
2021 · 5 years
Last commercial register change
March 27, 2026
Employees
21 to 50

Similar companies

AP
Azurity Pharmaceuticals Switzerland GmbH
Zug
AP
Aphaia Pharma AG
Zug
AT
Aurealis Therapeutics AG
Zug
BS
Bristol-Myers Squibb Products SA
Steinhausen